 | • レポートコード：MRC2012A5547 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、肝硬変治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。肝硬変治療薬の種類別市場規模（経口、注射）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Gilead Sciences、Gwo Xi Stem Cell Applied Technology、Merck、GlaxoSmithKline、Conatus Pharmaceuticals、Johnson & Johnson、Intercept Pharmaceuticals、Bristol-Myers Squibb、Roche、Instituto Grifols、Stempeutics Research、NGM Biopharmaceuticals、Salix Pharmaceuticals、Norgine、Pharmicell、 ・地域別グローバル市場分析 2015年-2020年 ・肝硬変治療薬の北米市場（アメリカ、カナダ、メキシコ） ・肝硬変治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・肝硬変治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・肝硬変治療薬の南米市場（ブラジル、アルゼンチン） ・肝硬変治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、注射 ・用途別分析：病院、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Liver Cirrhosis Therapeutics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Liver Cirrhosis Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Liver Cirrhosis Therapeutics Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Liver Cirrhosis Therapeutics Drugs market has been segmented into
Oral
Injection
By Application, Liver Cirrhosis Therapeutics Drugs has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Liver Cirrhosis Therapeutics Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Liver Cirrhosis Therapeutics Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Liver Cirrhosis Therapeutics Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Liver Cirrhosis Therapeutics Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Liver Cirrhosis Therapeutics Drugs Market Share Analysis
Liver Cirrhosis Therapeutics Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Liver Cirrhosis Therapeutics Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Liver Cirrhosis Therapeutics Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Liver Cirrhosis Therapeutics Drugs are:
Gilead Sciences
Gwo Xi Stem Cell Applied Technology
Merck
GlaxoSmithKline
Conatus Pharmaceuticals
Johnson & Johnson
Intercept Pharmaceuticals
Bristol-Myers Squibb
Roche
Instituto Grifols
Stempeutics Research
NGM Biopharmaceuticals
Salix Pharmaceuticals
Norgine
Pharmicell
Among other players domestic and global, Liver Cirrhosis Therapeutics Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liver Cirrhosis Therapeutics Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liver Cirrhosis Therapeutics Drugs, with price, sales, revenue and global market share of Liver Cirrhosis Therapeutics Drugs in 2018 and 2019.
Chapter 3, the Liver Cirrhosis Therapeutics Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liver Cirrhosis Therapeutics Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Liver Cirrhosis Therapeutics Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Liver Cirrhosis Therapeutics Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Liver Cirrhosis Therapeutics Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Liver Cirrhosis Therapeutics Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Liver Cirrhosis Therapeutics Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Overview of Global Liver Cirrhosis Therapeutics Drugs Market
1.4.1 Global Liver Cirrhosis Therapeutics Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Gilead Sciences SWOT Analysis
2.1.4 Gilead Sciences Product and Services
2.1.5 Gilead Sciences Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gwo Xi Stem Cell Applied Technology
2.2.1 Gwo Xi Stem Cell Applied Technology Details
2.2.2 Gwo Xi Stem Cell Applied Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Gwo Xi Stem Cell Applied Technology SWOT Analysis
2.2.4 Gwo Xi Stem Cell Applied Technology Product and Services
2.2.5 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Conatus Pharmaceuticals
2.5.1 Conatus Pharmaceuticals Details
2.5.2 Conatus Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Conatus Pharmaceuticals SWOT Analysis
2.5.4 Conatus Pharmaceuticals Product and Services
2.5.5 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Intercept Pharmaceuticals
2.7.1 Intercept Pharmaceuticals Details
2.7.2 Intercept Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Intercept Pharmaceuticals SWOT Analysis
2.7.4 Intercept Pharmaceuticals Product and Services
2.7.5 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bristol-Myers Squibb SWOT Analysis
2.8.4 Bristol-Myers Squibb Product and Services
2.8.5 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Instituto Grifols
2.10.1 Instituto Grifols Details
2.10.2 Instituto Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Instituto Grifols SWOT Analysis
2.10.4 Instituto Grifols Product and Services
2.10.5 Instituto Grifols Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Stempeutics Research
2.11.1 Stempeutics Research Details
2.11.2 Stempeutics Research Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Stempeutics Research SWOT Analysis
2.11.4 Stempeutics Research Product and Services
2.11.5 Stempeutics Research Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 NGM Biopharmaceuticals
2.12.1 NGM Biopharmaceuticals Details
2.12.2 NGM Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 NGM Biopharmaceuticals SWOT Analysis
2.12.4 NGM Biopharmaceuticals Product and Services
2.12.5 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Salix Pharmaceuticals
2.13.1 Salix Pharmaceuticals Details
2.13.2 Salix Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Salix Pharmaceuticals SWOT Analysis
2.13.4 Salix Pharmaceuticals Product and Services
2.13.5 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Norgine
2.14.1 Norgine Details
2.14.2 Norgine Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Norgine SWOT Analysis
2.14.4 Norgine Product and Services
2.14.5 Norgine Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Pharmicell
2.15.1 Pharmicell Details
2.15.2 Pharmicell Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Pharmicell SWOT Analysis
2.15.4 Pharmicell Product and Services
2.15.5 Pharmicell Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Liver Cirrhosis Therapeutics Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Liver Cirrhosis Therapeutics Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Liver Cirrhosis Therapeutics Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Liver Cirrhosis Therapeutics Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Liver Cirrhosis Therapeutics Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Liver Cirrhosis Therapeutics Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.5 South America Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Liver Cirrhosis Therapeutics Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Liver Cirrhosis Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Liver Cirrhosis Therapeutics Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Liver Cirrhosis Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.3 UK Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.4 France Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Liver Cirrhosis Therapeutics Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Liver Cirrhosis Therapeutics Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.5 India Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Liver Cirrhosis Therapeutics Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Liver Cirrhosis Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Liver Cirrhosis Therapeutics Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Liver Cirrhosis Therapeutics Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Liver Cirrhosis Therapeutics Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Liver Cirrhosis Therapeutics Drugs Price by Type (2015-2020)
11 Global Liver Cirrhosis Therapeutics Drugs Market Segment by Application
11.1 Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Application (2015-2020)
11.2 Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Liver Cirrhosis Therapeutics Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Liver Cirrhosis Therapeutics Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Liver Cirrhosis Therapeutics Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Liver Cirrhosis Therapeutics Drugs Market Forecast (2021-2025)
12.2.2 Europe Liver Cirrhosis Therapeutics Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Liver Cirrhosis Therapeutics Drugs Market Forecast (2021-2025)
12.2.4 South America Liver Cirrhosis Therapeutics Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Liver Cirrhosis Therapeutics Drugs Market Forecast (2021-2025)
12.3 Liver Cirrhosis Therapeutics Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Liver Cirrhosis Therapeutics Drugs Market Share Forecast by Type (2021-2025)
12.4 Liver Cirrhosis Therapeutics Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Liver Cirrhosis Therapeutics Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Liver Cirrhosis Therapeutics Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Liver Cirrhosis Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Liver Cirrhosis Therapeutics Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 8. Gilead Sciences Liver Cirrhosis Therapeutics Drugs Major Business
Table 9. Gilead Sciences Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Gilead Sciences SWOT Analysis
Table 11. Gilead Sciences Liver Cirrhosis Therapeutics Drugs Product and Services
Table 12. Gilead Sciences Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Gwo Xi Stem Cell Applied Technology Basic Information, Manufacturing Base and Competitors
Table 14. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Major Business
Table 15. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Gwo Xi Stem Cell Applied Technology SWOT Analysis
Table 17. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Product and Services
Table 18. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merck Basic Information, Manufacturing Base and Competitors
Table 20. Merck Liver Cirrhosis Therapeutics Drugs Major Business
Table 21. Merck Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Merck SWOT Analysis
Table 23. Merck Liver Cirrhosis Therapeutics Drugs Product and Services
Table 24. Merck Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 26. GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Major Business
Table 27. GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 28. GlaxoSmithKline SWOT Analysis
Table 29. GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Product and Services
Table 30. GlaxoSmithKline Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Conatus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Major Business
Table 33. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Conatus Pharmaceuticals SWOT Analysis
Table 35. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Product and Services
Table 36. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 38. Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Major Business
Table 39. Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Johnson & Johnson SWOT Analysis
Table 41. Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Product and Services
Table 42. Johnson & Johnson Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Intercept Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Major Business
Table 45. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Intercept Pharmaceuticals SWOT Analysis
Table 47. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Product and Services
Table 48. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 50. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Major Business
Table 51. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Bristol-Myers Squibb SWOT Analysis
Table 53. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Product and Services
Table 54. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Roche Basic Information, Manufacturing Base and Competitors
Table 56. Roche Liver Cirrhosis Therapeutics Drugs Major Business
Table 57. Roche Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Roche SWOT Analysis
Table 59. Roche Liver Cirrhosis Therapeutics Drugs Product and Services
Table 60. Roche Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Instituto Grifols Basic Information, Manufacturing Base and Competitors
Table 62. Instituto Grifols Liver Cirrhosis Therapeutics Drugs Major Business
Table 63. Instituto Grifols Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Instituto Grifols SWOT Analysis
Table 65. Instituto Grifols Liver Cirrhosis Therapeutics Drugs Product and Services
Table 66. Instituto Grifols Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Stempeutics Research Basic Information, Manufacturing Base and Competitors
Table 68. Stempeutics Research Liver Cirrhosis Therapeutics Drugs Major Business
Table 69. Stempeutics Research Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Stempeutics Research SWOT Analysis
Table 71. Stempeutics Research Liver Cirrhosis Therapeutics Drugs Product and Services
Table 72. Stempeutics Research Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. NGM Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Major Business
Table 75. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 76. NGM Biopharmaceuticals SWOT Analysis
Table 77. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Product and Services
Table 78. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Major Business
Table 81. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Salix Pharmaceuticals SWOT Analysis
Table 83. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Product and Services
Table 84. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Norgine Basic Information, Manufacturing Base and Competitors
Table 86. Norgine Liver Cirrhosis Therapeutics Drugs Major Business
Table 87. Norgine Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 88. Norgine SWOT Analysis
Table 89. Norgine Liver Cirrhosis Therapeutics Drugs Product and Services
Table 90. Norgine Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Pharmicell Basic Information, Manufacturing Base and Competitors
Table 92. Pharmicell Liver Cirrhosis Therapeutics Drugs Major Business
Table 93. Pharmicell Liver Cirrhosis Therapeutics Drugs Total Revenue (USD Million) (2017-2018)
Table 94. Pharmicell SWOT Analysis
Table 95. Pharmicell Liver Cirrhosis Therapeutics Drugs Product and Services
Table 96. Pharmicell Liver Cirrhosis Therapeutics Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Liver Cirrhosis Therapeutics Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 98. Global Liver Cirrhosis Therapeutics Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Liver Cirrhosis Therapeutics Drugs Sales by Regions (2015-2020) (K Pcs)
Table 100. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Regions (2015-2020)
Table 101. Global Liver Cirrhosis Therapeutics Drugs Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Liver Cirrhosis Therapeutics Drugs Sales by Countries (2015-2020) (K Pcs)
Table 103. North America Liver Cirrhosis Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 104. North America Liver Cirrhosis Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 106. Europe Liver Cirrhosis Therapeutics Drugs Sales by Countries (2015-2020) (K Pcs)
Table 107. Europe Liver Cirrhosis Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 108. Europe Liver Cirrhosis Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Liver Cirrhosis Therapeutics Drugs Sales by Regions (2015-2020) (K Pcs)
Table 110. Asia-Pacific Liver Cirrhosis Therapeutics Drugs Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Liver Cirrhosis Therapeutics Drugs Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Liver Cirrhosis Therapeutics Drugs Sales by Countries (2015-2020) (K Pcs)
Table 113. South America Liver Cirrhosis Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 114. South America Liver Cirrhosis Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales by Countries (2015-2020) (K Pcs)
Table 117. Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Liver Cirrhosis Therapeutics Drugs Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Table 120. Global Liver Cirrhosis Therapeutics Drugs Sales by Type (2015-2020) (K Pcs)
Table 121. Global Liver Cirrhosis Therapeutics Drugs Sales Share by Type (2015-2020)
Table 122. Global Liver Cirrhosis Therapeutics Drugs Revenue by Type (2015-2020) (USD Million)
Table 123. Global Liver Cirrhosis Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 124. Global Liver Cirrhosis Therapeutics Drugs Sales by Application (2015-2020) (K Pcs)
Table 125. Global Liver Cirrhosis Therapeutics Drugs Sales Share by Application (2015-2020)
Table 126. Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 127. Global Liver Cirrhosis Therapeutics Drugs Market Share Forecast by Regions (2021-2025)
Table 128. Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 129. Global Liver Cirrhosis Therapeutics Drugs Market Share Forecast by Type (2021-2025)
Table 130. Global Liver Cirrhosis Therapeutics Drugs Sales Forecast by Application (2021-2025)
Table 131. Global Liver Cirrhosis Therapeutics Drugs Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Liver Cirrhosis Therapeutics Drugs Picture
Figure 2. Global Sales Market Share of Liver Cirrhosis Therapeutics Drugs by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. Liver Cirrhosis Therapeutics Drugs Sales Market Share by Application in 2018
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Other Picture
Figure 9. Global Liver Cirrhosis Therapeutics Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Liver Cirrhosis Therapeutics Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Liver Cirrhosis Therapeutics Drugs Sales Market Share by Manufacturer in 2019
Figure 30. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Liver Cirrhosis Therapeutics Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Liver Cirrhosis Therapeutics Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 35. Global Liver Cirrhosis Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Regions (2015-2020)
Figure 37. Global Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Regions in 2018
Figure 38. North America Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 39. Europe Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 41. South America Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020)
Figure 43. North America Liver Cirrhosis Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Liver Cirrhosis Therapeutics Drugs Sales Market Share by Countries (2015-2020)
Figure 45. North America Liver Cirrhosis Therapeutics Drugs Sales Market Share by Countries in 2018
Figure 46. North America Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Countries in 2018
Figure 48. United States Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 49. Canada Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 50. Mexico Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Europe Liver Cirrhosis Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 54. Germany Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. UK Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. France Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Italy Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Asia-Pacific Liver Cirrhosis Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Liver Cirrhosis Therapeutics Drugs Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Regions 2019
Figure 62. China Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Korea Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. India Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Southeast Asia Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. South America Liver Cirrhosis Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Liver Cirrhosis Therapeutics Drugs Sales Market Share by Countries in 2019
Figure 69. South America Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 70. Brazil Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Argentina Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Middle East and Africa Liver Cirrhosis Therapeutics Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Liver Cirrhosis Therapeutics Drugs Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Liver Cirrhosis Therapeutics Drugs Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Egypt Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Turkey Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. South Africa Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Global Liver Cirrhosis Therapeutics Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 81. Global Liver Cirrhosis Therapeutics Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Liver Cirrhosis Therapeutics Drugs Market Forecast (2021-2025) (K Pcs)
Figure 83. Europe Sales Liver Cirrhosis Therapeutics Drugs Market Forecast (2021-2025) (K Pcs)
Figure 84. Asia-Pacific Sales Liver Cirrhosis Therapeutics Drugs Market Forecast (2021-2025) (K Pcs)
Figure 85. South America Sales Liver Cirrhosis Therapeutics Drugs Market Forecast (2021-2025) (K Pcs)
Figure 86. Middle East & Africa Sales Liver Cirrhosis Therapeutics Drugs Market Forecast (2021-2025) (K Pcs)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
肝硬変治療薬の世界市場（～2026年） Market Analysis and Insights: Global Liver Cirrhosis Therapeutics Market The global Liver Cirrhosis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Liver Cirrhosis Therapeutics Scope and Market Size Liver …- 肝硬変の世界市場（～2026年） Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse. Alcohol has been identified as the strongest risk factor for liver cirrhosis. Market Analysis and Insights: Global Liver Cirrhosis Market The global Liver Cirrhosis …
- 肝疾患治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Liver Diseases Therapeutics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Liver Disea…
- 非アルコール性脂肪肝疾患治療薬の世界市場（～2026年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …
- 慢性肝疾患治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Liver Diseases Therapeutics Market The global Chronic Liver Diseases Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…